Among women included in the analysis, 379 (12%) of BRCA1 PV carriers, 646 (20%) of BRCA2 PV carriers and 645 (23%) of non-carriers experienced natural menopause prior to RRSO, a cancer diagnosis (apart from non-melanoma skin cancer) or interview (Table 1). Here, BRCA2 is linked to cancer.